Loading
Total declarations
Companies
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Dec 2013 for Eloxx Pharmaceuticals, Inc., €2,426.
Insider track record
Disclosed buys
10
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
10
Positive at T+90
40%
Median T+90
-3.4%
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +3.7%Entry US$2,160.00 · Close at T+365 US$2,240.00
- -77.3%Entry US$17,600.00 · Close at T+365 US$4,000.00
- -18.5%Entry US$21,600.00 · Close at T+365 US$17,600.00
- -13.0%Entry US$23,200.00 · Close at T+365 US$20,192.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Leslie J. Browne: trading record in brief
Filings by Leslie J. Browne span 3 companies, the busiest being Pharmacopeia Drug Discovery Inc, Eloxx Pharmaceuticals, Inc. and Genelabs Technologies Inc /CA. Over a trading history stretching from 31 January 2006 to 19 December 2013, the count stands at 25 filings.
No open-market sale appears; the market trades are 10 purchases worth €13k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 14 share grants. So far in 2013, the count stands at 2 purchases and no sales.
In size, the median ticket on the buying side is €1,233. After 5 purchases with a full 90-day history, the hit rate stands at 40% and the median 90-day move at -3.4%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 20 December 2013 with an open-market purchase (€2,426) in Eloxx Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Leslie J. Browne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
800 shares@ US$4.15Common StockSEC:0001144204-13-068373:0
Canonical exit: 19 Mar 2014 (T+90)
30,000 shares@ US$0.04Common StockSEC:0001144204-13-030696:0
Canonical exit: 18 Aug 2013 (T+90)
10,000 shares@ US$0.26Common StockSEC:0001144204-12-018331:0
Canonical exit: 27 Jun 2012 (T+90)
3,000 shares@ US$0.2683Common StockSEC:0001179110-11-005327:0
Canonical exit: 19 Jun 2011 (T+90)
3,000 shares@ US$0.2855Common StockSEC:0001179110-11-003315:0
Canonical exit: 24 May 2011 (T+90)
3,000 shares@ US$0.2884Common StockSEC:0001179110-11-003315:1
Canonical exit: 25 May 2011 (T+90)
10,000 shares@ US$1.30Common StockSEC:0001217624-09-000001:0
97.61 shares@ US$3.35Common StockSEC:0001273013-08-000029:0
1,201.97 shares@ US$3.65Common StockSEC:0001273013-08-000013:0
268.34 shares@ US$3.68Common StockSEC:0001273013-08-000004:0
235.68 shares@ US$4.19Common StockSEC:0001382436-08-000002:0
800 shares@ US$4.46Common StockSEC:0001300293-07-000005:0
Canonical exit: 4 Mar 2008 (T+90)
200 shares@ US$4.45Common StockSEC:0001300293-07-000005:1
Canonical exit: 4 Mar 2008 (T+90)
500 shares@ US$4.55Common StockSEC:0001300293-07-000005:2
Canonical exit: 5 Mar 2008 (T+90)
500 shares@ US$4.50Common StockSEC:0001300293-07-000005:3
Canonical exit: 6 Mar 2008 (T+90)
65.11 shares@ US$5.99Common StockSEC:0001273013-07-000044:0
168.8 shares@ US$5.85Common StockSEC:0001273013-07-000029:0
605.89 shares@ US$5.69Common StockSEC:0001273013-07-000022:0
206.1 shares@ US$4.67Common StockSEC:0001273013-07-000003:0
217.76 shares@ US$4.42Common StockSEC:0001300293-07-000001:0
817.88 shares@ US$5.93Common StockSEC:0001273013-06-000046:0
156 shares@ US$6.17Common StockSEC:0001273013-06-000024:0
969.65 shares@ US$5.93Common StockSEC:0001273013-06-000017:0
181.16 shares@ US$4.83Common StockSEC:0001273013-06-000010:0
201.61 shares@ US$4.34Common StockSEC:0001273013-06-000009:0
25 of 25 declarations
